Header Logo

Connection

CHARLES MINARD to Ipilimumab

Back to Details
This is a "connection" page, showing publications CHARLES MINARD has written about Ipilimumab.
CHARLES MINARD
Connection Strength
0.051
Ipilimumab
  1. A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412. Clin Cancer Res. 2022 12 01; 28(23):5088-5097.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.